Marker TherapeuticsMRKR
13F holders, Q3 2024 (September 30)1holders
0new positions
0sold out
$2.82avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Marker Therapeutics Inc. (MRKR) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holder was Ar Asset Management Inc. ($208K).
- Company
- Marker Therapeutics Inc.
- CUSIP
- 57055L107
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 3,000 shares bought, net +3,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Ar Asset Management Inc. | 0.05% | Add +4.2% | 73,700 | $208K |
"% of holder's portfolio" is MRKR's weight in each manager's 13F, not the share of Marker Therapeutics Inc. the manager owns.